fda approves nulojix for kidney transplant patients
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

FDA approves Nulojix for kidney transplant patients

Arab Today, arab today

Arab Today, arab today FDA approves Nulojix for kidney transplant patients

Washington - Xinhua

The U.S. Food and Drug Administration (FDA) on Wednesday approved Nulojix to prevent acute rejection in adult patients who have had a kidney transplant. The drug is approved for use with other immunosuppressants. Nulojix is a type of drug called a selective T-cell costimulation blocker. The drug helps to prevent organ rejection after a kidney transplant. Without immunosuppression, the body can reject a transplanted organ because the immune system recognizes the new organ as foreign (transplant rejection). By preventing rejection, Nulojix, given through 30 minute intravenous infusions, works with other immunosuppressants to keep the new kidney working. "Nulojix is a new option for kidney transplant patients," said Edward Cox, director of Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research. "This new medication used in combination with other immunosuppressants helps control the immune system and prevents organ rejection in patients receiving kidney transplants." Nulojix was evaluated in two open-label, randomized, multicenter, controlled Phase 3 studies that enrolled more than 1, 200 patients and compared two dose regimens of Nulojix with another immunosuppressant, cyclosporine. These trials demonstrated that the recommended Nulojix regimen is safe and effective for the prevention of acute organ rejection. According to the FDA, common adverse reactions observed in transplant patients in the trials included low red blood count, constipation, kidney or bladder infection, and swollen legs, ankles, or feet. More than 89,000 patients are waiting for a kidney transplant in the United States, according to the Organ Procurement and Transplantation Network, which is overseen by Department of Health and Human Service's Health Resources and Services Administration.

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

fda approves nulojix for kidney transplant patients fda approves nulojix for kidney transplant patients

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

fda approves nulojix for kidney transplant patients fda approves nulojix for kidney transplant patients

 



GMT 09:37 2012 Saturday ,28 April

Asamoah Gyan celebrates UAE title

GMT 06:57 2017 Tuesday ,12 December

Latest Grateful Dead resurrection -- a duo

GMT 14:03 2017 Friday ,10 February

3 Chinese miners killed in accident in Albania

GMT 10:06 2018 Sunday ,14 January

Qanso, Kijian tackle recent developments

GMT 18:58 2017 Saturday ,04 March

Gold prices continue to fall

GMT 12:49 2017 Thursday ,24 August

Fadl Shaker could be arrested soon

GMT 02:06 2017 Monday ,30 October

May22/Jun21

GMT 22:28 2017 Thursday ,24 August

February20th-March20th

GMT 08:07 2017 Saturday ,18 November

BBA President visits BHA

GMT 02:27 2017 Saturday ,28 October

September24th-October23rd

GMT 14:20 2017 Saturday ,26 August

Former VW engineer gets 40 months
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday